The Binding Site Optilite Caeruloplasmin Kit - Taiwan Registration 044c0eb9032f46f884138bad11f31f33
Access comprehensive regulatory information for The Binding Site Optilite Caeruloplasmin Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 044c0eb9032f46f884138bad11f31f33 and manufactured by THE BINDING SITE GROUP LTD. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
044c0eb9032f46f884138bad11f31f33
Ministry of Health Medical Device Import No. 032938
DHA05603293803
Product Details
This product is paired with the Binding Site Plite Analyzer for in vitro quantitative analysis of ceruloplasmin in human serum and heparin lithium salt plasma to help diagnose copper metabolism disorders.
C Immunology and microbiology devices
C5270 C-reactive protein immunoassay system
Imported from abroad
Dates and Status
Oct 14, 2019
Oct 14, 2024